Ginkgo Bioworks Holdings (DNA) Non-cash Items (2020 - 2023)
Ginkgo Bioworks Holdings (DNA) reported Non-cash Items of $8.7 million for Q2 2023, down 80.09% on a YoY basis from $43.7 million in Q2 2022, and up 3.38% quarter-over-quarter from $8.4 million in Q1 2023.
Ginkgo Bioworks Holdings (DNA) Non-cash Items (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings has reported Non-cash Items for 4 years, with the latest figure at $8.7 million in Q2 2023.
- For the quarter ending Q2 2023, Non-cash Items fell 80.09% year-over-year to $8.7 million; the trailing twelve-month figure through Jun 2023 stood at $8.7 million (down 80.09% YoY), and the FY2022 full-year result was $9.5 million, down 94.86% from the prior year.
- Non-cash Items for Q2 2023 stood at $8.7 million, up from $8.4 million in the prior quarter.
- The five-year high for Non-cash Items was $386.0 million in Q4 2020, with the low at $8.4 million in Q1 2023.
- Historically, Non-cash Items has averaged $122.7 million across 4 years, with a median of $50.9 million in 2022.
- Annual changes were most pronounced in 2021 — Non-cash Items slumped 51.91% — and 2022, when it plunged 94.86%.
- Ginkgo Bioworks Holdings' Non-cash Items stood at $386.0 million in 2020, then plunged by 51.91% to $185.6 million in 2021, then sank by 94.86% to $9.5 million in 2022, then declined by 8.77% to $8.7 million in 2023.
- The last three Non-cash Items figures came in at $8.7 million (Q2 2023), $8.4 million (Q1 2023), and $9.5 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 8.71 Mn |
| Jun 30, 2023 | 8.71 Mn |
| Mar 31, 2023 | 8.42 Mn |
| Mar 31, 2023 | 8.42 Mn |
| Dec 31, 2022 | 9.54 Mn |
| Dec 31, 2022 | 9.54 Mn |
| Sep 30, 2022 | 50.89 Mn |
| Sep 30, 2022 | 50.89 Mn |
| Jun 30, 2022 | 43.73 Mn |
| Jun 30, 2022 | 43.73 Mn |
| Mar 31, 2022 | 74.48 Mn |
| Mar 31, 2022 | 74.48 Mn |
| Dec 31, 2021 | 185.62 Mn |
| Dec 31, 2021 | 185.62 Mn |
| Sep 30, 2021 | 337.10 Mn |
| Sep 30, 2021 | 337.10 Mn |
| Dec 31, 2020 | 386.02 Mn |
| Dec 31, 2020 | 386.02 Mn |